Literature DB >> 15948112

Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases.

Nelson G Ordóñez1.   

Abstract

Mesotheliomas with clear cell morphology are rare and only a few individual case reports have been documented in the literature. The author reports a series of 20 epithelioid mesotheliomas with clear features, 17 of which originated in the pleura and 3 in the peritoneum. Eighteen of the patients were men and 2 were women. Twelve patients had a history of asbestos exposure. Electron microscopy and special histochemical stains demonstrated that the cytoplasmic clearing seen in hematoxylin and eosin-stained sections resulted from multiple factors that can occur either singly or in combination. The most frequent cause of the cytoplasmic clearing was the accumulation of large amounts of intracytoplasmic glycogen. Another but somewhat less common factor was the accumulation of large amounts of lipid, which occurred alone or with glycogen. Other less common causes were marked mitochondrial swelling, the presence of numerous intracytoplasmic vesicles, and a large number of intracytoplasmic lumens. The value of immunohistochemistry in helping to distinguish epithelioid mesotheliomas from some carcinomas with clear cell morphology is emphasized. In addition, it was determined that because electron microscopy was decisive in establishing the cause of the cytoplasmic clearing in most of the cases, tissue for electron microscopy should routinely be procured for ultrastructural studies.

Entities:  

Mesh:

Year:  2005        PMID: 15948112     DOI: 10.1016/j.humpath.2005.02.014

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  My approach to the diagnosis of mesothelial lesions.

Authors:  K J Butnor
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

2.  Diagnostic difficulties and pitfalls in rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration.

Authors:  Sara E Monaco; Matthew J Schuchert; Walid E Khalbuss
Journal:  Cytojournal       Date:  2010-06-14       Impact factor: 2.091

3.  Lymphangiomatoid pattern in diffuse malignant mesothelioma of the pleura: a report of six cases.

Authors:  Ruchira Ruangchira-urai; Eugene J Mark
Journal:  Virchows Arch       Date:  2009-07-18       Impact factor: 4.064

4.  DNA methylation profile of 28 potential marker loci in malignant mesothelioma.

Authors:  Jeffrey A Tsou; Janice S Galler; Anil Wali; Wei Ye; Kimberly D Siegmund; Susan Groshen; Peter W Laird; Sally Turla; Michael N Koss; Harvey I Pass; Ite A Laird-Offringa
Journal:  Lung Cancer       Date:  2007-07-30       Impact factor: 5.705

Review 5.  Introduction to the second edition of 'Diagnostic Cytopathology of Serous Fluids' as CytoJournal Monograph (CMAS) in Open Access.

Authors:  Vinod B Shidham; Lester J Layfield
Journal:  Cytojournal       Date:  2021-12-06       Impact factor: 2.091

Review 6.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

Review 7.  Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature.

Authors:  Xiao-Ming Lin; Chuang Chi; Jun Chen; Yu Liu; Peng Li; Yi Yang
Journal:  J Cardiothorac Surg       Date:  2013-03-17       Impact factor: 1.637

8.  Malignant peritoneal mesothelioma in a patient with intestinal fistula, incisional hernia and abdominal infection: A case report.

Authors:  Sen Hong; Miao-Miao Bi; Ping-Wei Zhao; X U Wang; Qing-Yang Kong; Yong-Tao Wang; Lei Wang
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

9.  Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report.

Authors:  Xue-Mei Du; Ya-Ping Wei; Ying Gao; Zhao Li; Jian-Mei Zhang; Hong Chang; Yan Li
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.